Instil Bio, Inc. (TIL)
NASDAQ: TIL · Real-Time Price · USD
10.92
-0.48 (-4.21%)
At close: Dec 5, 2025, 4:00 PM EST
11.34
+0.42 (3.85%)
After-hours: Dec 5, 2025, 7:47 PM EST
Instil Bio Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Revenue | - | - | - | - | - | 0.14 | |
| Gross Profit | - | - | - | - | - | 0.14 | |
| Selling, General & Admin | 33.65 | 46.33 | 50.91 | 69.34 | 51.31 | 13.48 | |
| Research & Development | 24.13 | 13.63 | 39.63 | 136.83 | 103.96 | 18.47 | |
| Operating Expenses | 57.78 | 59.96 | 90.54 | 206.17 | 155.27 | 31.95 | |
| Operating Income | -57.78 | -59.96 | -90.54 | -206.17 | -155.27 | -31.82 | |
| Interest Expense | -7.27 | -8.99 | -5.21 | -1.88 | - | - | |
| Interest & Investment Income | 4.46 | 6.99 | 8.87 | 3.66 | 0.08 | - | |
| Other Non Operating Income (Expenses) | 8.57 | 1.41 | -0.58 | -0.56 | -1.28 | -3.94 | |
| EBT Excluding Unusual Items | -52.02 | -60.55 | -87.46 | -204.96 | -156.46 | -35.76 | |
| Merger & Restructuring Charges | -16.97 | -7.49 | -72.01 | -5.43 | - | -0.9 | |
| Impairment of Goodwill | - | - | - | -5.7 | - | - | |
| Asset Writedown | - | - | - | -1.93 | - | - | |
| Other Unusual Items | 3.91 | 3.91 | 3.38 | 2.88 | -0.29 | -0.93 | |
| Pretax Income | -75.08 | -74.14 | -156.09 | -225.25 | -156.76 | -37.59 | |
| Income Tax Expense | - | - | - | -2.07 | 0.04 | 0.15 | |
| Net Income | -75.08 | -74.14 | -156.09 | -223.18 | -156.79 | -37.74 | |
| Net Income to Common | -75.08 | -74.14 | -156.09 | -223.18 | -156.79 | -37.74 | |
| Shares Outstanding (Basic) | 7 | 7 | 7 | 6 | 5 | 1 | |
| Shares Outstanding (Diluted) | 7 | 7 | 7 | 6 | 5 | 1 | |
| Shares Change (YoY) | 1.53% | 0.10% | 0.44% | 22.19% | 562.55% | 62.05% | |
| EPS (Basic) | -11.37 | -11.39 | -24.00 | -34.46 | -29.59 | -47.18 | |
| EPS (Diluted) | -11.37 | -11.39 | -24.00 | -34.46 | -29.59 | -47.18 | |
| Free Cash Flow | -40.1 | -55.7 | -102.69 | -264.75 | -179.97 | -80.43 | |
| Free Cash Flow Per Share | -6.07 | -8.55 | -15.79 | -40.88 | -33.96 | -100.55 | |
| Gross Margin | - | - | - | - | - | 100.00% | |
| Operating Margin | - | - | - | - | - | -23055.07% | |
| Profit Margin | - | - | - | - | - | -27346.38% | |
| Free Cash Flow Margin | - | - | - | - | - | -58284.06% | |
| EBITDA | -56.52 | -56.35 | -85.79 | -200.18 | -152.51 | -31.56 | |
| D&A For EBITDA | 1.26 | 3.61 | 4.76 | 5.99 | 2.75 | 0.26 | |
| EBIT | -57.78 | -59.96 | -90.54 | -206.17 | -155.27 | -31.82 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.